TCT-8 Fate of deferred lesions using state-of-art percutaneous coronary revascularization in patients with de novo three vessel disease: lesion level analysis at 2 years of the SYNTAX II study

Article2017

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan, Giovanni Luigi De Maria, Simon Walsh, Manel Sabaté, Justin E. Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Stephan P Hoole, Nick E.J. West, Jan J. Piek, Azfar Zaman, Farzin Fath‐Ordoubadi, Rod Stables, Clare Appleby, Nicolas M. Van Mieghem, Robert J. Van Geuns, Neal Uren, Javier Zueco, Paweł Buszman, Andrés Íñiguez, Javier Goicolea, David Hildick‐Smith, Andrzej Ochała, Dariusz Dudek, Colm G. Hanratty, Rafael Cavalcante, A. Pieter Kappetein, David P. Taggart, Gerrit‐Anne van Es, Marie‐Angèle Morel, Ton de Vries, Yoshinobu Onuma, Vasim Farooq, Patrick W. Serruys, Adrian Banning

European Heart Journal

Article2021

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with <i>de novo</i> three-vessel disease: final results of the SYNTAX II study

Adrian Banning, Patrick W. Serruys, Giovanni Luigi De Maria, Nicola Ryan, Simon Walsh, Nieves Gonzalo, Robert‐Jan van Geuns, Yoshinobu Onuma, Manel Sabaté, Justin E. Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Stephen P. Hoole, Jan J. Piek, Clare Appleby, Farzin Fath‐Ordoubadi, Azfar Zaman, Nicolas M. Van Mieghem, Neal Uren, Javier Zueco,

Article2012

TCT-43 Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Friedrich Mohr, Simon Redwood, G E Venn, Antonio Colombo, Michael J. Mack, A. Pieter Kappetein, Marie‐Claude Morice, David R. Holmes, Ted Feldman, Elisabeth Ståhle, Keith D. Dawkins, Patrick W. Serruys

Journal of the American College of Cardiology

Article2019

TCT-111 Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for Three Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Yuki Katagiri, Taku Asano, Rod Stables, Simon Walsh, Manel Sabaté, Justin E. Davies, Jan J. Piek, Robert‐Jan van Geuns, Johan Reiber, Vasim Farooq, Adrian Banning, Javier Escaned, Patrick W. Serruys, Yoshinobu Onuma

Journal of the American College of Cardiology

Article2019

278Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease: 3-year follow-up of the SYNTAX II study

Patrick W. Serruys, Simon Walsh, Manel Sabaté, Justine Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Nick E.J. West, Jan J. Piek, Rod Stables, Nicolas M. Van Mieghem, Vasim Farooq, Javier Escaned, Adrian Banning, Yoshinobu Onuma